Crude and adjusted hazard ratios for chronic kidney disease among women with and without postpartum hypertension and diabetes during follow-up
| Group | Chronic kidney disease | Incidence rate per 10 000 person-years | Crude HR (95% CI) | Adjusted HR* (95% CI) |
|---|---|---|---|---|
| No hypertensive disorder in pregnancy | 90 | 0.67 | 1.00 | 1.00 |
| Hypertensive disorder in pregnancy | 121 | 7.24 | 10.8 (8.20–14.2) | 9.38 (7.09–12.4) |
| Hypertension during follow-up | ||||
| No hypertensive disorders in pregnancy | 43 | 86.6 | 1.00 | 1.00 |
| Hypertensive disorders in pregnancy | 94 | 121 | 1.39 (0.97–2.00) | 1.35 (0.94–1.94) |
| No hypertension during follow-up | ||||
| No hypertensive disorders in pregnancy | 47 | 0.35 | 1.00 | 1.00 |
| Hypertensive disorders in pregnancy | 27 | 1.69 | 4.81 (3.00–7.72) | 4.37 (2.71–7.07) |
| Diabetes during follow-up | ||||
| No hypertensive disorders in pregnancy | 5 | 2.12 | 1.00 | 1.00 |
| Hypertensive disorders in pregnancy | 19 | 19.4 | 9.20 (3.43–24.6) | 7.62 (2.80–20.8) |
| No diabetes during follow-up | ||||
| No hypertensive disorders in pregnancy | 85 | 0.64 | 1.00 | 1.00 |
| Hypertensive disorders in pregnancy | 102 | 6.47 | 10.0 (7.53–13.4) | 8.92 (6.65–12.0) |
Note: CI = confidence interval, HR = hazard ratio.
↵* Adjusted for urban status, coronary artery disease, congestive heart failure, hyperlipidemia and abruption.